Agents that can detect cancer at this stage with an imaging technique, such as CT, will significantly increase our ability to detect cancer during regular check-up visits,, said Raghuraman Kannan, Ph.D., a member of the research team and an assistant professor in the Department of Radiology at the University of Missouri.
,Toxicity studies of nanoparticles need to be thoroughly investigated before we proceed further in utilizing them for a clinical setting,, Dr. Kannan
One advantage that may catalyze efforts toward human testing is that the same CT scanners already in use in hospitals can be used if gold nanoparticles are part of contrast imaging.
"Nanoparticles would be ideal candidates in CT diagnosis of different diseases such as cancer, asthma, emphysema and cystic fibrosis, , said Dr. Katti. ,We hope that nanoparticles will increase the sensitivity, as well as the scope of diagnostic imaging.,
undefined(back row, from left) Evan Boote, PH.D., Robert Churchill, M.D., Amanda Tinsley, B.S., Sharanya Bhaskaran, B.S., Ravi pandrapragada, M.S. (front row, from left) Kavita Katti, B.S., Kattesh V. Katti, Ph.D., Raghuraman Kannan, Ph.D., Leah Arrigo, B.S., Chandrika Mysore, M.S.